Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 3 | 2018 | 1426 | 0.830 |
Why?
|
| Neoplasms | 3 | 2022 | 1033 | 0.710 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 756 | 0.710 |
Why?
|
| Awareness | 1 | 2019 | 59 | 0.680 |
Why?
|
| Hot Temperature | 1 | 2019 | 120 | 0.670 |
Why?
|
| Intention | 1 | 2019 | 84 | 0.660 |
Why?
|
| Curcumin | 1 | 2018 | 66 | 0.630 |
Why?
|
| Smad4 Protein | 1 | 2017 | 6 | 0.610 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2017 | 39 | 0.600 |
Why?
|
| Glucose | 1 | 2018 | 217 | 0.590 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 48 | 0.570 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 396 | 0.570 |
Why?
|
| Lactic Acid | 1 | 2016 | 87 | 0.570 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 183 | 0.530 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 49 | 0.520 |
Why?
|
| Glycolysis | 1 | 2015 | 66 | 0.520 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 117 | 0.510 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 336 | 0.440 |
Why?
|
| Inflammation | 1 | 2017 | 577 | 0.440 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 465 | 0.400 |
Why?
|
| Phosphorylation | 3 | 2018 | 878 | 0.360 |
Why?
|
| Hong Kong | 4 | 2023 | 8 | 0.330 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 2128 | 0.280 |
Why?
|
| Disease Progression | 2 | 2018 | 580 | 0.260 |
Why?
|
| NF-kappa B | 2 | 2018 | 306 | 0.260 |
Why?
|
| Humans | 12 | 2023 | 34853 | 0.240 |
Why?
|
| Female | 6 | 2021 | 19873 | 0.220 |
Why?
|
| Animals | 5 | 2022 | 14307 | 0.210 |
Why?
|
| Fathers | 1 | 2021 | 26 | 0.200 |
Why?
|
| Tobacco Use Cessation | 1 | 2021 | 13 | 0.200 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1149 | 0.190 |
Why?
|
| Exosomes | 1 | 2022 | 97 | 0.190 |
Why?
|
| Behavior Therapy | 1 | 2021 | 145 | 0.190 |
Why?
|
| Mental Health | 1 | 2023 | 270 | 0.180 |
Why?
|
| Signal Transduction | 3 | 2017 | 1802 | 0.180 |
Why?
|
| Interpersonal Relations | 1 | 2021 | 198 | 0.180 |
Why?
|
| Apoptosis | 2 | 2017 | 1317 | 0.180 |
Why?
|
| Aerosols | 1 | 2019 | 48 | 0.170 |
Why?
|
| Acetylation | 1 | 2018 | 94 | 0.160 |
Why?
|
| Smoking Cessation | 2 | 2021 | 487 | 0.160 |
Why?
|
| Hyperglycemia | 1 | 2018 | 53 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 242 | 0.150 |
Why?
|
| Withanolides | 1 | 2017 | 8 | 0.150 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 26 | 0.150 |
Why?
|
| Social Class | 1 | 2019 | 228 | 0.150 |
Why?
|
| Hyperinsulinism | 1 | 2016 | 17 | 0.150 |
Why?
|
| Telomerase | 1 | 2017 | 40 | 0.150 |
Why?
|
| Ubiquitination | 1 | 2017 | 54 | 0.150 |
Why?
|
| Mice | 2 | 2018 | 5668 | 0.150 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 80 | 0.140 |
Why?
|
| Interleukin-6 | 1 | 2017 | 140 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 200 | 0.140 |
Why?
|
| Diabetes Complications | 1 | 2016 | 91 | 0.140 |
Why?
|
| Mice, Nude | 1 | 2017 | 323 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 416 | 0.140 |
Why?
|
| Health Status | 1 | 2019 | 356 | 0.140 |
Why?
|
| Age Factors | 1 | 2019 | 1007 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 480 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 211 | 0.140 |
Why?
|
| Deoxyglucose | 1 | 2015 | 19 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2015 | 35 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 325 | 0.130 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 50 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2016 | 177 | 0.130 |
Why?
|
| Models, Molecular | 1 | 2018 | 751 | 0.130 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 180 | 0.120 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 145 | 0.120 |
Why?
|
| Phenotype | 1 | 2016 | 650 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 145 | 0.120 |
Why?
|
| Cell Movement | 1 | 2017 | 545 | 0.120 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1300 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2015 | 287 | 0.110 |
Why?
|
| Adult | 4 | 2023 | 11034 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 984 | 0.110 |
Why?
|
| Cell Survival | 1 | 2015 | 818 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 413 | 0.110 |
Why?
|
| Male | 3 | 2021 | 18870 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2561 | 0.100 |
Why?
|
| Young Adult | 1 | 2019 | 4012 | 0.090 |
Why?
|
| Obesity | 1 | 2017 | 965 | 0.080 |
Why?
|
| Adolescent | 1 | 2019 | 5035 | 0.080 |
Why?
|
| Aged | 1 | 2019 | 6448 | 0.080 |
Why?
|
| Middle Aged | 1 | 2019 | 9642 | 0.070 |
Why?
|
| Breath Tests | 1 | 2021 | 24 | 0.050 |
Why?
|
| Carbon Monoxide | 1 | 2021 | 30 | 0.050 |
Why?
|
| Family Health | 1 | 2021 | 47 | 0.050 |
Why?
|
| Prenatal Care | 1 | 2021 | 74 | 0.050 |
Why?
|
| Ligands | 1 | 2022 | 317 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2023 | 358 | 0.050 |
Why?
|
| Communication | 1 | 2020 | 170 | 0.040 |
Why?
|
| Models, Biological | 1 | 2022 | 642 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2017 | 40 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 71 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 126 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2022 | 386 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2020 | 1353 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 1503 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 490 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 834 | 0.030 |
Why?
|